Guardant Health scores 100 mln Series D
Redwood City, California-based Guardant Health, a cancer testing provider, has raised almost $100 million in Series D funding. OrbiMed Advisors is leading the round with participation from other investors that include Khosla Ventures, Sequoia Capital, Lightspeed Venture Partners, Pejman Mar, Formation 8 and Heritage Group.
7 January 2016•3 mins read
